Clinical Trial Update: Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating ketamine oral rinse for oral mucositis in head and neck cancer patients; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Ketamine oral rinse (ketamine)

Snippet

Sponsor: University of Oklahoma | Conditions: Head and Neck Cancer | Phase 2 | Status: NOT_YET_RECRUITING